Apr 16 |
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
|
Apr 9 |
IGC Pharma Adds Advisor in Artificial Intelligence
|
Mar 26 |
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
|
Mar 20 |
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
|
Mar 20 |
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
|
Mar 12 |
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
|
Feb 28 |
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
|
Feb 23 |
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target
|
Feb 19 |
India Globalization Capital GAAP EPS of -$0.09 misses by $0.05, revenue of $0.2M misses by $0.02M
|
Feb 17 |
IGC Pharma Reports Third Quarter Fiscal 2024 Results
|